Brief: Herantis Pharma H2 Loss For Period Slightly Widens To EUR 4.8 Million

Herantis Pharma Oyj

03/03/2022 06:06

March 3 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * H2 LOSS FOR PERIOD EUR 4.8 MILLION VERSUS LOSS EUR 4.7
MILLION
YEAR AGO
    * H2 REVENUE EUR 0 VERSUS EUR 0 YEAR AGO

Source text for Eikon:  ID:nWkr6Krn1h 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))